Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2020-01-31

Original market date: See footnote 1

1999-04-29

Product name:

ALLEGRA-D

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02239853

Product Monograph/Veterinary Labelling:

Date: 2022-02-14 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

SANOFI CONSUMER HEALTH INC
2905 Place Louis-R Renaud
Laval
Quebec
Canada H7V 0A3

Class:

Human

Dosage form(s):

Tablet (Immediate And Extended Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

2

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

12:12.12  ,  04:08.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

R01BA52 PSEUDOEPHEDRINE, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0236381001

List of active ingredient(s)
Active ingredient(s) Strength
FEXOFENADINE HYDROCHLORIDE 60 MG
PSEUDOEPHEDRINE HYDROCHLORIDE 120 MG
Version 4.0.2
Date modified: